To study the effect of Drug Nivolumab in patients with cancers.
Not Applicable
- Conditions
- Health Condition 1: C819- Hodgkin lymphoma, unspecified
- Registration Number
- CTRI/2022/04/042179
- Lead Sponsor
- Christian Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i.Patients with primary progressive or relapsed Hodgkin lymphoma
ii.Signed and dated written informed consent by start date of Screening visit in accordance with GCP
Exclusion Criteria
i. Age <18years
ii. Pregnancy or lactation
iii. Hepatitis B, C or HIV
iv. Ejection fraction <40%
v. Total Bilirubin >3mg%
vi. Serum Creatinine > 2mg%
vii.ECOG performance score >3
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method